Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 661 AL 675

Alzheimer's disease current therapies, novel drug delivery systems and future directions for better disease management

Singh B, Day CM, Abdella S, Garg S.

J Control Release. 2024 Mar;367:402-424. doi: 10.1016/j.jconrel.2024.01.047. Epub 2024 Feb 1.

A comprehensive review of multi-target directed ligands in the treatment of Alzheimer's disease

Pathak C, Kabra UD.

Bioorg Chem. 2024 Mar;144:107152. doi: 10.1016/j.bioorg.2024.107152. Epub 2024 Jan 27.

Brain cholesterol and Alzheimer's disease: challenges and opportunities in probe and drug development

Ahmed H, Wang Y, Griffiths WJ, Levey AI, Pikuleva I, Liang SH, Haider A.

Brain. 2024 May 3;147(5):1622-1635. doi: 10.1093/brain/awae028.

A Comprehensive Review on Potential Molecular Drug Targets for the Management of Alzheimer's Disease

Sharma C, Mazumder A.

Cent Nerv Syst Agents Med Chem. 2024;24(1):45-56. doi: 10.2174/0118715249263300231116062740.

Marine-derived Compounds: A Powerful Platform for the Treatment of Alzheimer's Disease

Arora R, Babbar R, Dabra A, Chopra B, Deswal G, Grewal AS.

Cent Nerv Syst Agents Med Chem. 2024;24(2):166-181. doi: 10.2174/0118715249269050231129103002.

Muscarinic control of cardiovascular function in humans: a review of current clinical evidence

Palma JA.

Clin Auton Res. 2024 Feb;34(1):31-44. doi: 10.1007/s10286-024-01016-5. Epub 2024 Feb 2.

Occupational Therapy Practice Guidelines for Adults Living With Alzheimer's Disease and Related Neurocognitive Disorders

Smallfield S, Metzger L, Green M, Henley L, Rhodus EK.

Am J Occup Ther. 2024 Jan 1;78(1):7801397010. doi: 10.5014/ajot.2024.078101.

Psychedelics for alzheimer's disease-related dementia: Unveiling therapeutic possibilities and pathways

Sinha JK, Trisal A, Ghosh S, Gupta S, Singh KK, Han SS, Mahapatra M, Abomughaid MM, Abomughayedh AM, Almutary AG, Iqbal D, Bhaskar R, Mishra PC, Jha SK, Jha NK, Singh AK.

Ageing Res Rev. 2024 Apr;96:102211. doi: 10.1016/j.arr.2024.102211. Epub 2024 Feb 1.

Therapeutic potential of the medicinal mushroom Ganoderma lucidum against Alzheimer's disease

Chen XJ, Deng Z, Zhang LL, Pan Y, Fu J, Zou L, Bai Z, Xiao X, Sheng F.

Biomed Pharmacother. 2024 Mar;172:116222. doi: 10.1016/j.biopha.2024.116222. Epub 2024 Feb 3.

The effects of probiotic supplements on oxidative stress and inflammation in subjects with mild and moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled study

Akhgarjand C, Vahabi Z, Shab-Bidar S, Anoushirvani A, Djafarian K.

Inflammopharmacology. 2024 Apr;32(2):1413-1420. doi: 10.1007/s10787-023-01427-2. Epub 2024 Feb 6.

Memantine's double duty? Investigating its impact on epilepsy control in Alzheimer's disease

Rayala H, Kapur J, El-Haija HA, Parikh P, Zawar I.

Epileptic Disord. 2024 Apr;26(2):261-263. doi: 10.1002/epd2.20202. Epub 2024 Feb 9.

From the Mind to the Spine: The Intersecting World of Alzheimer's and Osteoporosis

Margetts TJ, Wang HS, Karnik SJ, Plotkin LI, Movila A, Oblak AL, Fehrenbacher JC, Kacena MA.

Curr Osteoporos Rep. 2024 Feb;22(1):152-164. doi: 10.1007/s11914-023-00848-w. Epub 2024 Feb 9.

Artificial intelligence for drug discovery and development in Alzheimer's disease

Qiu Y, Cheng F.

Curr Opin Struct Biol. 2024 Apr;85:102776. doi: 10.1016/j.sbi.2024.102776. Epub 2024 Feb 8.

Acid sphingomyelinase as a pathological and therapeutic target in neurological disorders: focus on Alzheimer's disease

Choi BJ, Park MH, Jin HK, Bae JS.

Exp Mol Med. 2024 Feb;56(2):301-310. doi: 10.1038/s12276-024-01176-4. Epub 2024 Feb 9.

Extra-Virgin Olive Oil in Alzheimer's Disease: A Comprehensive Review of Cellular, Animal, and Clinical Studies

Alkhalifa AE, Al-Ghraiybah NF, Kaddoumi A.

Int J Mol Sci. 2024 Feb 5;25(3):1914. doi: 10.3390/ijms25031914.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias